| 06.16.26 | 8 min read
FDA approves Wegovy (semaglutide) for chronic weight management. June 4, 2021
Belfiore A, Rapicavoli RV, Le Moli R, Lappano R, Morrione A, De Francesco EM et al
Sobobas focus on in-person care, physician guidance, and ongoing support positions the clinic as a strong local option for Ozempic weight-loss treatment
You start treatment with easy home delivery and continuous support from our care team
Anvisa itself noted it is among the first health agencies globally to register synthetic analogs of biologically derived drugs using this approach a classification that, if it holds and is replicated by other regulators, would position Brazil's synthetic semaglutide market closer to the steep price discounts seen in conventional generic drug launches (often 7090% in the first year of competition) than to the more modest reductions typical of biosimilar markets